Revance Therapeutics Inc (NASDAQ:RVNC)

BATS BZX Real-Time Price
As of 3:42pm ET
 +0.53 / +1.82%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Revance Therapeutics Inc have a median target of 37.00, with a high estimate of 55.00 and a low estimate of 33.00. The median estimate represents a +24.54% increase from the last price of 29.71.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Revance Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.72%
Growthannually 18.65%


Growthquarterly 10.69%
Growthannually 446.75%
Key to the earnings and sales forecast charts.